Op-Ed: State bills will ensure patients access to safe, advanced drugs

Published



Biological drugs are modern medical miracles. Derived from living organisms, this complex class of drugs — known as “biologics” — has proven astonishingly effective in treating a wide range of diseases, including rheumatoid arthritis, cancer, and a host of complex autoimmune disorders.

Thanks to the 2010 Patient Protection and Affordable Care Act, patients will soon have access to more affordable versions of these medicines. That legislation empowered the Food and Drug Administration to begin approving “biosimilars.”

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.